Overview - research biomedical area
Biomedical research carried out by Avantea is focusing on three main areas: animal models, stem cells and toxicological testing; all these three sectors rely on the application of advanced reproductive technologies.
In the biomedical field, Avantea has been involved in a large European research project, named Xenome, for the derivation of pigs with genetic characteristics that make them more compatible with human immunity. The goal was to generate pigs, by cloning, which could be tissue donors for humans. Other research projects, in which Avantea is collaborating, are exploring generation of pigs for experimental surgery; some of them are related to the production of pigs carrying marker genes that enable to identify their tissues after transplantation and the pig as an animal model to study human degenerative diseases.
In the area of stem cell Avantea is a partner in a European research project (Plurysis, FP7) and performs basic research on embryonic stem cells of bovine embryo as a model compared to the comparative model of mouse stem cells.
With regards to the use of reproductive technologies for biomedical purposes, Avantea as partner of the project Reprotect has developed some toxicological tests based on animal gametes and embryos. Avantea is also partner of the Esnats and Scr&tox reserach projects, in which the development of tests is based on stem cells of various origins. At international level, it is a strongly emerging area of research, which addresses the need to develop alternatives laboratory tests that do not require animal sacrifice, instead of using small rodents, usually used for conventional toxicological tests.
Animal Models
The animal model used at Avantea research centre is the pig, as its physiology is the closest to humans after primates.
In general, animal models are important for biomedical research because they can offer an approximation of human disease and may contribute to the understanding of the eziopathological mechanisms and to the development of treatments or prevention strategies.
The models developed by Avantea are pigs generated by combining genetic engineering together with the technique of somatic cloning. The procedure consists of the derivation of somatic cell lines (typically fibroblasts) with genetic characteristics partly modified by the introduction or removal of one or more genes of interest. Cells carrier of the desired characteristics are used in the cloning procedure to obtain cloned embryos that are transplanted into recipient sows. In this way animals carrying genetic modifications similar to those of human genetic diseases can be obtained creating an animal model for a particular disease.
In the same way, animals with genetic characteristics that would make them potential donors of cells and tissues for xenotransplantation or for the biotechnology industry can be obtained.
Avantea takes part in important research projects at national and European level (Translink, Xenoislet), collaborating with leading scientific institutions and universities in the field of xenotrasplantation and in particular related to the use of the pig as an animal model in biomedical and biotechnological research.
Publications
Vabres B, Le Bas-Bernardet S, Riochet D, Chérel Y, Minault D, Hervouet J, Ducournau Y, Moreau A, Daguin V, Coulon F, Pallier A, Brouard S, Robson SC, Nottle MB, Cowan PJ, Venturi E, Mermillod P, Brachet P, Galli C, Lagutina I, Duchi R, Bach JM, Blancho G, Soulillou JP, Vanhove B. hCTLA4-Ig transgene expression in keratocytes modulates rejection of corneal xenografts in a pig to non-human primate anterior lamellar keratoplasty model. Xenotransplantation. 2014 Jul 8. doi: 10.1111/xen.12107. [Epub ahead of print]
Chieppa MN, Perota A, Corona C, Grindatto A, Lagutina I, Vallino Costassa E, Lazzari G, Colleoni S, Duchi R, Lucchini F, Caramelli M, Bendotti C, Galli C, Casalone C. Modeling Amyotrophic Lateral Sclerosis in hSOD1 Transgenic Swine. Neurodegener Dis. 2014;13(4):246-54. doi: 10.1159/000353472. Epub 2013 Oct 23.
Busby SA, Crossan C, Godwin J, Petersen B, Galli C, Cozzi E,Takeuchi Y, Scobie L. Suggestions for the diagnosis and elimination of hepatitis E virus in pigs used for xenotransplantation. Xenotransplantation. 2013 May 7. doi: 10.1111/xen.12038
Naso F, Gandaglia A, Bottio T, Tarzia V, Nottle MB, d'Apice AJ, Cowan PJ, Cozzi E, Galli C, Lagutina I, Lazzari G, Iop L, Spina M, Gerosa G. First quantification of alpha-Gal epitope in current glutaraldehyde-fixed heart valve bioprostheses. Xenotransplantation. 2013 Jul-Aug;20(4):252-61. doi: 10.1111/xen.12044. Epub 2013 Jul 19.
Schubert T, Poilvache H, Galli C, Gianello P, Dufrane D. Galactosyl-knock-out engineered pig as a xenogenic donor source of adipose MSCs for bone regeneration. Biomaterials. 2013;34(13):3279-89.
Spiezia L, Boldrin M, Radu C, Bulato C, Bertini D, Bon M, Campello E, Vadori M, Galli C, Gavasso S, Nottle MB, Cowan PJ, Cozzi E, Simioni P Thromboelastographic evaluation of coagulative profiles in pig-to-monkey kidney xenotransplantation. Xenotransplantation. 2013;20(2):89-99
Galli C, Lagutina I, Perota A, Colleoni S, Duchi R, Lucchini F, Lazzari G. Somatic cell nuclear transfer and transgenesis in large animals: current and future insights. Reprod Domest Anim. 2012 Jun;47 Suppl 3:2-11. doi: 10.1111/j.1439-0531.2012.02045.x.
Le Bas-Bernardet S, Tillou X, Poirier N, Dilek N, Chatelais M, Devallière J, Charreau B, Minault D, Hervouet J, Renaudin K, Crossan C, Scobie L, Cowan PJ, d'Apice AJ, Galli C, Cozzi E, Soulillou JP, Vanhove B, Blancho G. Xenotransplantation of Galactosyl-Transferase Knockout, CD55, CD59, CD39, and Fucosyl-Transferase Transgenic Pig Kidneys Into Baboons. Transplant Proc. 2011 Nov;43(9):3426-30.
Chatelais M, Devallière J, Galli C, Charreau B. Gene transfer of the adaptor Lnk (SH2B3) prevents porcine endothelial cell activation and apoptosis: implication for xenograft's cytoprotection. Xenotransplantation. 2011 Mar;18(2):108-20.
Fahrenkrug SC, Blake A, Carlson DF, Doran T, Van Eenennaam A, Faber D, Galli C, Gao Q, Hackett PB, Li N, Maga EA, Muir WM, Murray JD, Shi D, Stotish R, Sullivan E, Taylor JF, Walton M, Wheeler M, Whitelaw B and Glenn BP "Precision genetics for complex objectives in animal agriculture" J Anim Sci 2010.88:2530-2539. doi: 10.2527/jas.2010-2847 originally published online Mar 12, 2010;
Galli C, Perota A, Brunetti D, Lagutina I, Lazzari G, Lucchini F. "Genetic engineering including superseding microinjection: new ways to make GM pigs". Xenotransplantation 2010; 17: 397–410. 2010 John Wiley & Sons A/S.
Sachs DH, Galli C Genetic manipulation in pigs Current Opinion in Organ Transplantation 2009, 14:148–153.
Brunetti D, Perota A, Lagutina I, Colleoni S, Duchi R, Calabrese F, Seveso M, Cozzi E, Lazzari G, Lucchini F, Galli C. Transgene Expression of Green Fluorescent Protein and Germ Line Transmission in Cloned Pigs Derived from In Vitro Transfected Adult Fibroblasts. Cloning Stem Cells 2008.
Lagutina, I, Lazzari, G. Galli, C. Birth of cloned pigs from zona-free nuclear transfer embryos developed in vitro to blastocyst before transfer. Cloning and Stem Cells Dec 2006, Vol. 8, No. 4: 283-293.
Stem cells
Embryonic stem cells have the characteristic of giving origin to all cell types that make up an animal or a human being. For this reason these cells are of great interest for biomedical research and are currently used in various areas of research. A first use is for the development of toxicological tests for drugs and chemical substances potentially harmful to embryonic development. Another important research area includes the study of differentiation into tissues in order to understand the molecular mechanisms and to develop protocols for obtaining cells suitable for tissue repair by transplantation (cell therapy).
Avantea research activity in the field of embryonic stem cells is carried out within European research projects (Esnats, Scr&Tox and Plurisys), focused on the development of toxicological tests,and on the study of the mechanisms that govern pluripotency of embryonic stem cells and drive their differentiation.
Publications
Rossi B, Merlo B, Colleoni S, Iacono E, Tazzari PL, Ricci F, Lazzari G, Galli C. Isolation and in Vitro Characterization of Bovine Amniotic Fluid Derived Stem Cells at Different Trimesters of Pregnancy. Stem Cell Rev. 2014 Jun 7. [Epub ahead of print]
Czernik M, Fidanza A, Sardi M, Galli C, Brunetti D, Malatesta D, Della Salda L, Matsukawa K, Ptak G, Loi P. Differentiation potential and GFP labeling of sheep bone marrow derived mesenchymal stem cells. J Cell Biochem. 2013 Jan;114(1):134-43.
Lazzari G, Colleoni S, Galli C. Derivation of neural precursors from bovine preimplantation embryos. Methods Mol Biol. 2013;1074:199-207. doi: 10.1007/978-1-62703-628-3_15.
Colleoni S, Galli C, Giannelli SG, Armentero MT, Blandini F, Broccoli V, Lazzari G. Long-term culture and differentiation of CNS precursors derived from anterior human neural rosettes following exposure to ventralizing factors. Exp Cell Res. 2010 Apr.
Colleoni S, Bottani E, Tessaro I, Mari G, Merlo B, Romagnoli N, Spadari A, Galli C, Lazzari G. Isolation, growth and differentiation of equine mesenchymal stem cells: effect of donor, source, amount of tissue and supplementation with basic fibroblast growth factor. Vet Res Commun. 2009 Dec;33(8):811-21.
Fulka J, Jr., Fulka H, St John J, Galli C, Lazzari G, Lagutina I, Fulka J, Loi P. Cybrid human embryos - warranting opportunities to augment embryonic stem cell research. Trends Biotechnol 2008 Sep;26(9):469-74.
Santoni de Sio FR, Gritti A, Cascio P, Neri M, Sampaolesi M, Galli C, Luban J, Naldini L. Lentiviral Vector Gene Transfer is Limited by the Proteasome at Post-Entry Steps in Various Types of Stem Cells. Stem Cells 2008 Aug;26(8):2142-52.
Lombardo A, Beausejour CM, Genovese P, Colleoni S, Lee Y-L,Kim KA, Ando D, Urnov F, Galli C, Gregory PD, Holmes MC, Naldini L. Gene editing and site-specific gene additino in human stem cells using designed zinc finger nucleases and integrase detective lentiviral vector delivery. Nat Biotechnol. 2007 Nov;25(11):1298-306. Epub 2007 Oct 28.
Lazzari, G., Colleoni, S., Giannelli, S. G., Brunetti, D., Colombo, E., Lagutina, I., Galli, C., and Broccoli, V. Direct derivation of neural rosettes from cloned bovine blastocysts: a model of early neurulation events and neural crest specification in vitro. Stem Cells. 2006 Nov;24(11):2514-21. Epub 2006 Aug 24.
Colleoni S, Donofrio G, Lagutina I, Duchi R, Galli C, Lazzari G. Establishment, differentiation, electroporation, viral transduction, and nuclear transfer of bovine and porcine mesenchymal stem cells. Cloning Stem Cells. 2005;7(3):154-66.
Donofrio G, Colleoni S, Galli C, Lazzari G, Cavirani S, Flammini CF. Susceptibility of bovine mesenchymal stem cells to bovine herpesvirus 4. J Virol Methods. 2005 Aug;127(2):168-70.
Galli, C., Lazzari, G., Flechon, J-E & Moor, R.M. (1994). Embryonic stem cells in farm animals. Zygote 2: 385-389.
Toxicity testing
The development of in vitro toxicity testing is a research area rapidly expanding in all developed countries; this is because, first, it aims to reduce the use of laboratory animals for toxicology testing, and secondly to provide industry with effective methods for testing potential toxic effects of different chemicals. For this reason the European Union is supporting through funding programmes a number of integrated research projects in order to encourage the growth of in vitro toxicological tests.
Avantea has been involved in different European research projects:
- Avantea was one of the partners of the European project ReProTect (2004-2009). Within this project, Avantea developed two in vitro tests used to detect toxic effects on bovine gametes (during oocyte maturation and fertilization). Similarly animal embryos and embryonic stem cells represent a valuable biological model for in vitro studies on embryo toxicity. This line of research promises to provide chemical and pharmaceutical industry with new and sensitive techniques for toxicology studies in reproductive field.
- Avantea was partner of the European project ESNATS (Embryonic Stem cell-based Novel Alternative Testing Strategies 2008-2013) that aimed to develop new approaches for chemicals testing based on embryonic stem cells. The aim was, firstly, to increase drug development, through an initial screening using in vitro technologies with high efficiency and, secondly, substantially decrease the use of animals required for conventional toxicity tests.
- Avantea is also partner of the European project Scr&tox, together with 13 international organizations (industrial and academic), with the objectives of developing alternatives to toxicological testing for the European cosmetics industry, to increase the reliability of chemicals and cosmetics and to reduce the use of animal testing. The development of alternative toxicological tests is considered to be of fundamental importance for the whole European cosmetics industry, in order to protect human health by improving the safety and reliability of products. Together with five other projects, Scr&Tox, is part of a single European initiative funded by the European Commission and COLIPA, the European Association of Cosmetic Industry. The purpose of Scr&Tox is to generate new techniques and methods of analysis for toxicity testing of cosmetic products and drugs before they can be placed on the market.
Publications
- Reuven EM, Leviatan Ben-Arye S, Yu H, Duchi R, Perota A, Conchon S, et al. Biomimetic Glyconanoparticle Vaccine for Cancer Immunotherapy. ACS nano. 2019.
- Perota A, Lagutina I, Duchi R, Zanfrini E, Lazzari G, Judor JP, et al. Generation of cattle knockout for galactose-alpha1,3-galactose and N-glycolylneuraminic acid antigens. Xenotransplantation. 2019:e12524.
- Crociara P, Chieppa MN, Vallino Costassa E, Berrone E, Gallo M, Lo Faro M, et al. Motor neuron degeneration, severe myopathy and TDP-43 increase in a transgenic pig model of SOD1-linked familiar ALS. Neurobiology of disease. 2019;124:263-75.
- Trapani I, Perota A, Tiberi P, Colecchi L, Lagutina I, Duchi R, et al.Genome Editing to Generate a Pig Model of Stargardt Disease Type 1.Molecular Therapy. 2018;26:403-4.
- Scobie L, Galli C, Gianello P, Cozzi E, Schuurman HJ. Cellular xenotransplantation of animal cells into people: benefits and risk. Revue scientifique et technique (International Office of Epizootics). 2018;37:113-22.
- Linda S, Claire C, I. MN, Cesare G, Andrea P, Pierre G. Viral pathogens: What are they and do they matter? Xenotransplantation. 2018;25:e12412.
- Quadalti C, Brunetti D, Lagutina I, Duchi R, Perota A, Lazzari G, et al. SURF1 knockout cloned pigs: Early onset of a severe lethal phenotype. Biochim Biophys Acta. 2018;1864:2131-42.<
- Barone A, Benktander J, Whiddon C, Jin C, Galli C, Teneberg S, et al. Glycosphingolipids of porcine, bovine, and equine pericardia as potential immune targets in bioprosthetic heart valve grafts. Xenotransplantation. 2018;25:e12406.
- Salama A, Mosser M, Leveque X, Perota A, Judor JP, Danna C, et al. Neu5Gc and alpha1-3 GAL Xenoantigen Knockout Does Not Affect Glycemia Homeostasis and Insulin Secretion in Pigs. Diabetes. 2017;66:987-93.
- Naso F, Stefanelli U, Buratto E, Lazzari G, Perota A, Galli C, et al. Alpha-Gal Inactivated Heart Valve Bioprostheses Exhibit an Anti-Calcification Propensity Similar to Knockout Tissues().Tissue Eng Part A. 2017;23:1181-95.
- Mourad NI, Perota A, Xhema D, Galli C, Gianello P. Transgenic Expression of Glucagon-Like Peptide-1 (GLP-1) and Activated Muscarinic Receptor (M3R) Significantly Improves Pig Islet Secretory Function. Cell transplantation. 2017;26:901-11.<
- Duisit J, Orlando G, Debluts D, Maistriaux L, Xhema D, de Bisthoven YJ, et al. Decellularization of the Porcine Ear Generates a Biocompatible, Nonimmunogenic Extracellular Matrix Platform for Face Subunit Bioengineering. Annals of surgery. 2017.
- Barandalla M, Shi H, Xiao H, Colleoni S, Galli C, Lio P, et al. Global gene expression profiling and senescence biomarker analysis of hESC exposed to H2O2 induced non-cytotoxic oxidative stress. Stem Cell Res Ther. 2017;8:160.
- Barandalla M, Haucke E, Fischer B, Navarrete Santos A, Colleoni S, Galli C, et al. Comparative Analysis of AGE and RAGE Levels in Human Somatic and Embryonic Stem Cells under H2O2-Induced Noncytotoxic Oxidative Stress Conditions. Oxid Med Cell Longev. 2017;2017:4240136.
- Rubio A, Luoni M, Giannelli SG, Radice I, Iannielli A, Cancellieri C, et al. Rapid and efficient CRISPR/Cas9 gene inactivation in human neurons during human pluripotent stem cell differentiation and direct reprogramming. Sci Rep. 2016;6:37540.
- Reynard O, Jacquot F, Evanno G, Mai HL, Salama A, Martinet B, et al. Anti-EBOV GP IgGs Lacking alpha1-3-Galactose and Neu5Gc Prolong Survival and Decrease Blood Viral Load in EBOV-Infected Guinea Pigs. PLoS One. 2016;11:e0156775.
- Quadalti C, Galli C, Lazzari G. Development of an in vitro test battery for the screening of the receptor-mediated mechanism and the spindle-poison mode of action of estrogenic compounds. Environ Toxicol Pharmacol. 2016;48:245-52.
- Perota A, Lagutina I, Quadalti C, Lazzari G, Cozzi E, Galli C. The Applications of Genome Editing in Xenotransplantation.Journal of Genetics and Genomics. 2016;43:233-7.
- Butler JR, Martens GR, Estrada JL, Reyes LM, Ladowski JM, Galli C, et al. Silencing porcine genes significantly reduces human-anti-pig cytotoxicity profiles: an alternative to direct complement regulation. Transgenic Res. 2016.
- Buist M, Komatsu E, Lopez P, L. G, Bodnar E, Salama A, et al. Features of N-Glycosylation of Immunoglobulins from Knockout Pig Models J Anal Bioanal Tech. 2016;7.
- Tessaro I, Modina SC, Crotti G, Franciosi F, Colleoni S, Lodde V, et al. Transferability and inter-laboratory variability assessment of the in vitro bovine oocyte fertilization test. Reprod Toxicol. 2015;51C:106-13.
- Paulis M, Castelli A, Susani L, Lizier M, Lagutina I, Focarelli ML, et al. Chromosome transplantation as a novel approach for correcting complex genomic disorders. Oncotarget. 2015;6:35218-30.
- Le Bas-Bernardet S, Tillou X, Branchereau J, Dilek N, Poirier N, Châtelais M, et al. Bortezomib, C1-Inhibitor and Plasma Exchange Do Not Prolong the Survival of Multi-Transgenic GalT-KO Pig Kidney Xenografts in Baboons. American Journal of Transplantation. 2015;15:358-70.
- Colleoni S, Galli C, Gaspar JA, Meganathan K, Jagtap S, Hescheler J, Zagoura D, Bremer S, Sachinidis A, Lazzari G. A comparative transcriptomic study on the effects of valproic acid on two different hESCs lines in a neural teratogenicity test system. Toxicol Lett. 2014 Sep 2;231(1):38-44. doi: 10.1016/j.toxlet.2014.08.023. [Epub ahead of print]
- Chieppa MN, Perota A, Corona C, Grindatto A, Lagutina I, Vallino Costassa E, Lazzari G, Colleoni S, Duchi R, Lucchini F, Caramelli M, Bendotti C, Galli C, Casalone C. Modeling Amyotrophic Lateral Sclerosis in hSOD1 Transgenic Swine.Neurodegener Dis. 2014;13(4):246-54. doi: 10.1159/000353472. Epub 2013 Oct 23.
- Colleoni S, Galli C, Gaspar JA, Meganathan K, Jagtap S, Hescheler J, Zagoura D, Bremer S, Sachinidis A, Lazzari G. A comparative transcriptomic study on the effects of valproic acid on two different hESCs lines in a neural teratogenicity test system. Toxicol Lett. 2014 Sep 2;231(1):38-44. doi: 10.1016/j.toxlet.2014.08.023. [Epub ahead of print]
- Colleoni S, Galli C, Gaspar JA, Meganathan K, Jagtap S, Hescheler J, Sachinidis A, Lazzari G. Characterisation of a neural teratogenicity assay based on human ESCs differentiation following exposure to valproic acid. Curr Med Chem. 2012 Dec 1;19(35):6065-71.
- Colleoni S, Galli C, Gaspar JA, Meganathan K, Jagtap S, Hescheler J, Sachinidis A, Lazzari G. Development of a neural teratogenicity test based on human embryonic stem cells: response to retinoic Acid exposure. Toxicol Sci. 2011 Dec;124(2):370-7.
- Lorenzetti S, Altieri I, Arabi S, Balduzzi D, Bechi N, Cordelli E, Galli C, Ietta F, Modina SC, Narciso L, Pacchierotti F, Villani P, Galli A, Lazzari G, Luciano AM, Paulesu L, Spanò M, Mantovani A. Innovative non-animal testing strategies for reproductive toxicology: the contribution of Italian partners within the EU project ReProTect. Ann Ist Super Sanita. 2011;47(4):429-44. Review.
- Luciano AM, Franciosi F, Lodde V, Corbani D, Lazzari G, Crotti G, Galli C, Pellizzer C, Bremer S, Weimer M, Modina SC.Transferability and inter-laboratory variability assessment of the in vitro bovine oocyte maturation (IVM) test within ReProTect.Reprod Toxicol. 2010 Aug;30(1):81-8
- Schenk B, Weimer M, Bremer S, van der Burg B, Cortvrindt R, Freyberger A, Lazzari G, Pellizzer C, Piersma A, Schäfer WR, Seiler A, Witters H, Schwarz M. The ReProTect Feasibility Study, a novel comprehensive in vitro approach to detect reproductive toxicants. Reprod Toxicol. 2010 Aug;30(1):200-18
- Lazzari G, Tessaro I, Crotti G, Galli C, Hoffmann S, Bremer S, Pellizzer C. Development of an in vitro test battery for assessing chemical effects on bovine germ cells under the ReProTect umbrella. Toxicol Appl Pharmacol. 2008; 233:360-70.
- Bremer S, Balduzzi D, Cortvrindt R, Daston G, Eletti B, Galli A, Huhtaniemi I, Laws S, Lazzari G, Liminga U, Smitz J, Spano M, Themmen A, Tilloy A, Waalkens-Behrends I. The effects of chemicals on mammalian fertility. The report and recommendations of ECVAM Workshop 53--the first strategic workshop of the EU ReProTect Project. Altern Lab Anim. 2005 Aug;33(4):391-416. Full text.